BeOne Medicines (Nasdaq:ONC) today announced the investment of $300 million to expand its U.S. manufacturing base. The expansion comes at the company’s flagship clinical and commercial-stage manufacturing and R&D center in Hopewell, New Jersey. It brings BeOne’s total U.S. manufacturing investment to more than $1 billion. BeOne said its latest expansion increases its production capacity…
Otsuka ICU Medical to invest $500M in IV solutions manufacturing in the US
Otsuka ICU Medical today announced plans to invest more than $500 million to expand its U.S. IV solutions manufacturing in Texas. The companies (Otsuka Pharmaceutical Factory and ICU Medical), which launched this joint venture last year, plan to deliver a new facility and significant upgrades to its existing operations in Austin, Texas. They expect the…
Evonik to invest $100M in US drug contract manufacturing site
Evonik announced today that it plans to invest $100 million to expand its pharmaceutical manufacturing capabilities in the U.S. The Essen, Germany-based company is investing in its Tippecanoe Labs site in Lafayette, Indiana, which houses one of the world’s largest facilities for the production of active pharmaceutical ingredients (APIs). Over the next five years, the…
Codis acquires oral solid dose plant from Catalent
Codis announced today that it agreed to acquire an oral solid dose (OSD) development and manufacturing plant from Catalent. Acquiring the Nottingham, UK-based facility will add OSD development and small-scale manufacturing capabilities to Codis’ offerings, enabling it to offer a single partner path for integrated spray dry solutions. It can now provide development through clinical…
Besins Healthcare acquires pharmaceutical manufacturing company UniD
Besins Healthcare announced today that it acquired UniD Manufacturing, a Belgium-based pharmaceutical development and manufacturing company. UniD specializes in long-acting drug-delivery technologies, bringing decades of expertise to Besins, which delivers a range of hormone therapies. The company works with advanced polymer technology for complex long-acting delivery systems, including implants and vaginal rings. The companies expect…
Shoko to begin manufacturing pharmaceutical product in Korea
Shoko announced today that it completed work on a manufacturing plant for its new pharmaceutical excipient, Viscomedi. The facility saw its full-scale commercial production commence in February 2026. Excipients are the inactive, non-drug substances formulated alongside an active pharmaceutical ingredient (API). South Korea-based Hannong Chemicals has been developing a partially neutralized polyacrylate product for pharmaceutical…
BD names new president of Pharmacy Automation biz
BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business. Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately. In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of…
Report: Octapharma to make $1.5B expansion in South Carolina
Octapharma is investing $1.5 billion to build a new massive complex, including manufacturing capabilities, in South Carolina, according to the Charlotte Business Journal. The Swiss company, which develops and manufactures medicines for hematology, immunotherapy and critical care, is behind an effort labeled “Project Palmetto Rock,” the report says. It states that York County Council held a meeting…
ten23 Health picks up new pharmaceutical manufacturing licenses
ten23 health announced today that it obtained GMP certifications for pharmaceutical manufacturing in a duo of Swiss facilities. The company secured licenses to manufacture and test advanced therapy medicinal product (ATMP) in its Basel and Visp, Switzerland, plants. It said this marks a significant milestone in the planned strategic expansion for the global contract development…
Schott Pharma invests $60M to expand vial production in Pennsylvania
Schott Pharma announced that it opened up new production lines for both standard and sterile ready-to-use (RTU) glass vials. The company invested more than $60 million, largely funded by the Biomedical Advanced Research and Development Authority (BARDA), to strengthen the resilience of the U.S. pharmaceutical supply chain. It hopes to ensure reliable domestic production of…